AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
NIAID expands university vaccine testing network.(Brief Article)
2002 JUL 24 - (NewsRx.com & NewsRx.net) -- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) has awarded seven new contracts that will expand and reorganize its network of university-based sites conducting clinical trials of promising vaccine candidates and therapies for infectious diseases.
The reconfigured Vaccine Treatment and Evaluation Units (VTEUs) will enable NIAID to fund more clinical trials focused on specific populations as well as larger trials of public health importance, including those related to biodefense and vaccine safety.
Established in 1962, the network is a national resource for vaccine development. VTEU investigators have tested and advanced vaccines for many diseases, including pneumonia, influenza, cholera, whooping cough, malaria, and tuberculosis.
Childhood vaccines and so-called combination vaccines - the delivery of several vaccines at the same time - have been and remain an important part of the network's research agenda. The first trial of an edible vaccine was conducted by VTEU researchers, and other novel vaccine delivery systems, such as an influenza vaccine delivered via a nasal spray, have been extensively tested through the network.
"For 40 years, the VTEUs have provided an important mechanism for conducting vaccine clinical trials in a variety of populations, including infants, children, adults, and specific high-risk populations," said NIAID Director Anthony S. Fauci, MD. "More recently, part of this network's mission has been to evaluate vaccines against possible agents of bioterrorism."
An important strength of the VTEU network is its ability to rapidly recruit and retain volunteers. Through the VTEUs, NIAID quickly designed and implemented a multicenter clinical trial to evaluate the feasibility of diluting existing ...
- PI's the limit: Langton IFA MD Colin Langton makes a plea for alternative cover...
- Magazine article from: Money Marketing Langton, Colin November 14, 2002 700+ words
...clean records who are approaching their November PI renewal may face a doubling or trebling in premiums...in effect, self-insuring as the average PI claim to date is under [pounds sterling]20,000. PI insurance is not even mentioned in my FSA...
- Physician buy-in helps PI team reduce LOS.
- Newspaper article from: HealthCare Benchmarks and Quality Improvement March 1, 2004 700+ words
...challenges in any process improvement (PI) endeavor, was the key to success in a PI project undertaken by Peninsula Regional Medical Center in Salisbury, MD. The project, which targeted clinical PI in pneumonia, realized a reduction in...
- Critical Path Network: Physician buy-in helps PI team reduce LOS.
- Newspaper article from: Hospital Case Management June 1, 2004 700+ words
...challenges in any process improvement (PI) endeavor, was the key to success in a PI project undertaken by Peninsula Regional Medical Center in Salisbury, MD. The project, which targeted clinical PI in pneumonia, realized a reduction in...
- Performance anxiety: PI CME may be poised to become the predominant...
- Magazine article from: Medical Marketing & Media Iskowitz, Marc June 1, 2009 700+ words
...change. Bruce Bagley, MD, medical director...family physicians in PI CME because of the...out how to implement PI CME," observes Venkat Gullapalli, MD, CEO, Gullapalli...determinations." PI CME tips THE SOCIETY...OMITTED] Vincenza Snow, MD, FACP, director...
- Dual PI therapy emerges as most viable combination.
- Newspaper article from: AIDS Alert December 1, 1997 700+ words
...rallying cry for dual PI therapy was John Mellors, MD, director of the HIV...John Bartlett, MD, chief of infectious...accumulating data on dual PI therapy show that not...tolerated as single PI combination therapy...says Eugene Sun, MD, head of the antiviral...
- Dual PI therapy emerges as most viable combination: it could become standard of...
- Newspaper article from: AIDS Alert December 1, 1997 700+ words
...guidelines. The promise of dual PI therapy generated much...the rallying cry for dual PI therapy was John Mellors, MD, director of the HIV...lot," john Bartlett, MD, chief of infectious disease...accumulating data on dual PI therapy show that not only...
- Registration of `MD 402' Tobacco.
- Magazine article from: Crop Science AYCOCK, M.K. JR. May 1, 2000 700+ words
...and Education Center, and two farms in southern Maryland (1). Four standard cultivars: MD 609, MD 201, `MD 341' (7), and `MD 40' (PI 583833) (2), were included in the tests. The yield per hectare of MD 402 (1863 kg) was similar...
- Registration of MD 52ne high fiber quality cotton germplasm and recurrent...
- Magazine article from: Crop Science Meredith, W.R., Jr. March 1, 2005 700+ words
Cotton (Gossypium hirsutum L.) germplasm MD 52ne (Reg. no. GP-787, PI 634930) and its recurrent parent MD 90ne (Reg. no. GP-788, PI 634931) were developed by the USDA-ARS, Stoneville, MS, and released...
Source: HighBeam Research, NIAID expands university vaccine testing network.(Brief Article)